Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR

Ryo Ogawa1, Hideyuki Ishiguro, Yoshiyuki Kuwabara

  • 1Department of Oncology, Immunology, and Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan.

Insights

High levels of micro-RNA-129 (miR-129) correlate with poorer survival in esophageal squamous cell carcinoma (ESCC). This finding suggests miR-129 may be a significant prognostic factor for ESCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Understanding esophageal cancer's biological mechanisms is key for new therapies.
  • Micro-RNAs (miRNAs) are vital regulators in cellular processes.
  • Esophageal squamous cell carcinoma (ESCC) requires further investigation into its molecular underpinnings.

Purpose of the Study:

  • To analyze mature micro-RNA (miRNA) expression in ESCC.
  • To correlate miRNA expression with clinicopathological factors and patient prognosis.
  • To identify specific miRNAs as potential prognostic biomarkers for ESCC.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to quantify 73 mature miRNAs.
  • Expression levels were analyzed in 30 primary ESCC specimens.
  • Kaplan-Meier survival analysis and log-rank tests were employed to assess prognostic significance.

Main Results:

  • High expression of 6 out of 72 miRNAs was linked to significantly reduced patient survival.
  • Overexpression of miR-129 emerged as a significant, independent prognostic factor in surgically treated ESCC patients.
  • A high hazard ratio (18.11) for early death was associated with high miR-129 expression, validated in a separate test cohort.

Conclusions:

  • Elevated miR-129 expression is a significant indicator of poor prognosis in ESCC.
  • miR-129 may play a crucial role in the development and progression of esophageal cancer.
  • These findings support miR-129 as a potential biomarker for esophageal cancer prognosis.